CAVM up +1.93% percent Today $CAVM High is at 53.99 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
CAVM up +1.93% percent Today $CAVM High is at 53.99 and the Low 52.34 with current volume of 112,086.

Recent News posted below.

Cavium Inc CAVM other info.
http://investorshangout.com/Cavium-Inc-CAVM-53602/

CAVM Cavium Inc Recent Headline News

Technical Data on Semiconductors Stocks - Intel, Cavium, Advanced Semiconductor Engineering, Cirrus Logic, and PMC-Sierra
PR Newswire - Tue Nov 11, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Intel Corporation (NASDAQ: INTC), Cavium Inc. (NASDAQ: CAVM), Advanced Semiconductor Engineering Inc. (NYSE: ASX), Cirrus Logic Inc. (NASDAQ: CRUS), and PMC-Sierra Inc. (NASDAQ: PMCS). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, November 10, 2014, the NASDAQ Composite ended at 4,651.62, up 0.41%, the Dow Jones Industrial Average advanced 0.23%, to finish the day at 17,613.74, and the S&P 500 closed at 2,038.26, up 0.31%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Information Technology Sector Index ended the day at 676.73, up 0.26%, with the index also advancing 7.90% in the last one month. Register for your complimentary reports on these five stocks at:
CAVM: 53.80 (+0.93), ASX: 6.05 (+0.03), CRUS: 19.01 (-0.55), PMCS: 7.70 (+0.01), INTC: 33.60 (+0.22)

Cavium Networks Earnings In Retrospect: Up 14.8% in the Last 12 Days (CAVM)
Comtex SmarTrend(R) - Mon Nov 10, 12:23PM CST
When Cavium Networks (NASDAQ:CAVM) reported earnings a week ago on October 29th, 2014, analysts, on average, expected the company to report earnings of $0.39 on sales of $97.1 million. The company actually reported EPS of $0.40 on sales of $97.8 million, beating EPS estimates by $0.01 and beating revenue estimates by $0.8 million. Shares of Cavium Networks have climbed from $46.23 to $53.07, representing a gain of 14.8% since the company reported earnings 12 days ago.
CAVM: 53.80 (+0.93)

Upgrade Alert for Cavium Networks (CAVM)
Comtex SmarTrend(R) - Fri Nov 07, 7:02AM CST
Cavium Networks (NASDAQ:CAVM) was upgraded from Outperform to Strong Buy at Raymond James today. The stock closed yesterday at $52.29 on volume of 599,000 shares, below average daily volume of 948,000. Cavium Networks, Inc. provides semiconductor processors that enable intelligent networking, communications and security applications. The Company offers a broad portfolio of software compatible processors and accelerator boards ranging in performance from 10 Mbps to 10 Gbps.
CAVM: 53.80 (+0.93)

Stocks End Mildy Mixed, But Leading Growth Names Hit Hard
at Investor's Business Daily - Wed Nov 05, 3:35PM CST
Major averages ended mixed Wednesday. The Nasdaq lagged, but not by much, weighed down by weakness in 3D printing, solar, security and online travel stocks. At the close, the Dow Jones industrial average and S&P 500 scored new closing highs, rising...
MNST: 108.80 (+0.89), CAVM: 53.80 (+0.93), TSLA: 253.16 (+4.06), SWIR: 38.39 (+1.09), SWKS: 61.02 (+0.03), AKRX: 37.00 (+1.57), NXPI: 72.96 (-0.44), HAIN: 107.45 (+0.76), SCTY: 51.52 (-0.53), QCOM: 70.61 (+0.32), AVGO: 87.22 (+0.17), PAYC: 23.19 (+0.84)

Stocks Mixed In Late Trading; Tesla Earnings On Deck
at Investor's Business Daily - Wed Nov 05, 1:40PM CST
The Dow Jones industrial average and S&P 500 were slightly in the green, but tech stocks lagged with a little over one hour remaining in Wednesday's session. The Dow and S&P 500 each added 0.4%. The Nasdaq eased 0.1%. NYSE volume was tracking close...
TSLA: 253.16 (+4.06), CAVM: 53.80 (+0.93), AWAY: 31.01 (+0.21), TRIP: 69.73 (-0.65), NXPI: 72.96 (-0.44), PCLN: 1,163.40 (+2.40), PAYC: 23.19 (+0.84)

Cavium (CAVM) Jumps: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:57AM CDT
Cavium, Inc. (CAVM) was a big mover last session, as the company saw its shares rise over 7% on the day.
AMBA: 47.75 (-1.64), CAVM: 53.80 (+0.93), SUNE: 17.01 (-0.86), SIMO: 21.85 (-0.21)

Cavium Guidance, Earnings Top Despite 'Soft' China
at Investor's Business Daily - Thu Oct 30, 11:31AM CDT
Chipmaker Cavium (CAVM) late Wednesday reported better-than-expected Q4 guidance and Q3 earnings despite a soft China market, sending its stock rising Thursday. Cavium CEO Syed Ali said in a conference call with analysts that Q4 is expected to be the...
CAVM: 53.80 (+0.93)

Cavium's (CAVM) CEO Syed Ali on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 8:10PM CDT

CAVM: 53.80 (+0.93)

CAVIUM
at Investor's Business Daily - Wed Oct 29, 5:32PM CDT
CAVIUM (CAVM), a network chipmaker, said Q3 EPS rose 38% to 40 cents, a penny above. Sales grew 7.9% to $97.8 mil, edging views for $97.1 mil. Shares rose 4.9% to 48.50.
CAVM: 53.80 (+0.93)

Cavium tops Street 3Q forecasts
Automated Insights - Wed Oct 29, 5:21PM CDT
SAN JOSE, Calif. (AP) _ Cavium Inc. (CAVM) on Wednesday reported third-quarter profit of $5.4 million.
CAVM: 53.80 (+0.93)

Cavium Networks (CAVM) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 29, 3:55PM CDT

CAVM: 53.80 (+0.93)

Cavium Networks beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 3:21PM CDT

CAVM: 53.80 (+0.93)

Cavium Announces Financial Results for Q3 2014
PR Newswire - Wed Oct 29, 3:01PM CDT
Cavium, Inc. (NASDAQ: CAVM), a leading provider of highly integrated semiconductor products that enable intelligent processing for networking, communications, and the digital home, today announced financial results for the third quarter ended September 30, 2014.
CAVM: 53.80 (+0.93)

Stocks Rebound After Extending Losses
at Investor's Business Daily - Wed Oct 29, 2:09PM CDT
Stocks pared losses after stumbling to new session lows after the Federal Reserve ended its latest round of quantitative easing. The Nasdaq cut a 1% loss to 0.5%, while the S&P 500 shaved an 0.8% deficit to 0.4%. The Dow Jones industrial average was...
CAVM: 53.80 (+0.93), EXR: 58.40 (+0.50), PRAA: 62.11 (-0.22), VDSI: 27.23 (+0.82), V: 250.93 (-1.02), BIDU: 245.82 (-4.00), TRN: 35.74 (-0.32), FFIV: 125.99 (+0.23), CAR: 57.58 (-0.50), TRLA: 43.97 (-0.95), RGR: 37.53 (+0.31), SLCA: 41.67 (-1.08), SIMO: 21.85 (-0.21), BABA: 115.97 (-2.23)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:35PM CDT

CSGP: 159.52 (-2.49), CNW: 46.48 (-0.12), ACMP: 62.04 (+0.30), BGC: 13.81 (-0.12), DAC: 5.98 (unch), AIZ: 68.07 (-0.07), AEM: 24.03 (+0.27), ESRT: 15.96 (unch), CAR: 57.58 (-0.50), CWT: 25.31 (-0.19), AHL: 43.27 (-0.07), CLUB: 5.88 (-0.09), CAVM: 53.80 (+0.93), CJES: 18.88 (+0.17), FB: 74.35 (-0.37), AKAM: 60.56 (-0.22), EXR: 58.40 (+0.50), DWA: 25.77 (+3.40), EXL: 13.02 (+0.12), ANIK: 40.88 (-1.10), CLD: 12.71 (-0.43), ALL: 67.15 (-0.02), DRIV: 24.71 (+0.18), EQIX: 223.12 (+0.93), ESV: 38.26 (-1.01), ASGN: 30.40 (-0.61), AUY: 3.76 (-0.01), ACHC: 61.71 (+0.28), CALX: 10.92 (-0.15), CSII: 29.45 (-0.17), AFOP: 13.72 (-0.04), ARAY: 7.06 (+0.01), AEGN: 19.29 (-0.50), ATML: 7.54 (-0.03), CENX: 27.40 (-0.36), CUZ: 12.67 (+0.02), CACI: 86.33 (+0.46), ACGL: 57.68 (+0.26), AXS: 49.62 (+0.29), BMR: 21.70 (+0.14), ARII: 68.09 (-1.07), CBG: 32.70 (-0.01), CW: 71.22 (-0.30), DRE: 19.21 (+0.11), ABX: 11.79 (+0.06), CBL: 18.95 (+0.18), CHDN: 101.79 (-2.76), CMO: 12.69 (+0.04), CATM: 38.35 (+0.06), BLKB: 43.48 (-0.34), BIDU: 245.82 (-4.00), EQY: 24.11 (+0.13), ARRS: 28.42 (+0.01), ALDW: 18.10 (-0.77), CRUS: 19.01 (-0.55), CEMP: 14.28 (+0.11), CRL: 65.05 (+0.17)

Cavium Networks Has Returned 13.4% Since SmarTrend Recommendation (CAVM)
Comtex SmarTrend(R) - Mon Oct 27, 5:02PM CDT
SmarTrend identified a Downtrend for Cavium Networks (NASDAQ:CAVM) on September 15th, 2014 at $52.04. In approximately 1 month, Cavium Networks has returned 13.44% as of today's recent price of $45.04.
CAVM: 53.80 (+0.93)

Microsoft reportedly weighing support for ARM server CPUs
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 9:29AM CDT

CAVM: 53.80 (+0.93), MRVL: 12.97 (-0.36), AMD: 2.67 (-0.04), ARMH: 41.19 (-0.20), AMCC: 6.17 (-0.17), INTC: 33.60 (+0.22), MSFT: 49.38 (+0.60)

Intel Corporation Reveals New Server Chip Road Map
Ashraf Eassa, The Motley Fool - Motley Fool - Wed Oct 22, 8:00AM CDT
Every so often, Intel will publish an update to what the chipmaker calls its "public road map." In a nutshell, this is a rough overview of what products Intel has on the market across  its various segments and, in some cases, an estimate of when...
CAVM: 53.80 (+0.93), AMD: 2.67 (-0.04), ARMH: 41.19 (-0.20), AMCC: 6.17 (-0.17), INTC: 33.60 (+0.22)

Downtrend Call Working As Cavium Networks Stock Falls 15.7% (CAVM)
Comtex SmarTrend(R) - Mon Oct 20, 11:14AM CDT
SmarTrend identified a Downtrend for Cavium Networks (NASDAQ:CAVM) on September 15th, 2014 at $52.04. In approximately 1 month, Cavium Networks has returned 15.65% as of today's recent price of $43.89.
CAVM: 53.80 (+0.93)

Major Averages Pare Losses, Then Head Lower Again
at Investor's Business Daily - Wed Oct 15, 11:01AM CDT
Stocks headed lower again in late-morning trade after paring steep early losses sparked by weak economic data. The S&P 500 and Dow industrials sank 1.5% each, while the Nasdaq was down 1.3%. The tech-heavy index had earlier narrowed its deficit to...
AMBA: 47.75 (-1.64), BIIB: 317.10 (-3.92), CAVM: 53.80 (+0.93), NTES: 97.98 (+3.05), NXPI: 72.95 (-0.45), INTC: 33.60 (+0.22)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 63

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 85

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 192

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
John Wong's Decade as Estate Planning Specialist

Updated Category News Views 68

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

i3 Verticals' Strategic Shift Boosts Confidence in Future Growth

Updated Category News Views 53

i3 Verticals' Strategic Transformation Enhances Market Position i3 Verticals (NASDAQ: IIIV), recognized for providing integrated payment and software solutions, has recently received a boost in market confidence following the announcement of its significant $438 million divestiture. This strategic decision marks a pivotal moment for the company, allowing it to sharpen its...

Continue Reading
Understanding the Transformative Role of Placental Tissue for Healing

Updated Category News Views 93

Exploring the Benefits of Placental Allografts Marietta, GA – MiMedx Group, Inc. (NASDAQ: MDXG) has recently spotlighted the insights shared in a feature article about placental allografts, which focus on their application for healing complex wounds. This discussion surfaced through a compelling article in a major publication, highlighting the incredible advantages...

Continue Reading
Celebrate Impact: 13 Independent Coffee Shops Thriving Together

Updated Category News Views 326

Crimson Cup Supports Anniversaries of 13 Independent Coffee Shops Crimson Cup Coffee & Tea is proud to acknowledge the special anniversaries of 13 independent coffee houses this month. These remarkable shops are located in various states and have embraced their milestones, ranging from one year to an impressive 13 years of serving delicious coffee. The success these...

Continue Reading
Exploring Key UK Economic Trends Forecasted for 2025

Updated Category News Views 254

Insights on UK Economic Trends for 2025 The new year has arrived, and Deutsche Bank (ETR: DBKGn) has highlighted eight vital themes expected to influence the UK economy as we move further into 2025. Despite current uncertainties, analysts from Deutsche Bank express a level of optimism, indicating that government spending is likely to become a significant contributor to...

Continue Reading
Centene Corporation Reports Impressive Financial Results for 2024

Updated Category News Views 1146

Centene Corporation's Stellar 2024 Financial Overview Centene Corporation (NYSE: CNC) showcased robust financial performance for the year 2024, highlighted by a significant increase in diluted earnings per share (EPS) and revenue growth across various segments. The company's diluted EPS rose to $6.31, with an adjusted diluted EPS reaching $7.17, reflecting a 7% increase...

Continue Reading